Eagle Materials Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga Earnings
05/18

Eagle Materials Inc. (NYSE:EXP) will release earnings for its fourth quarter before the opening bell on Tuesday, May 19.

Analysts expect the Dallas, Texas-based company to report quarterly earnings of $1.54 per share, down from $2.00 per share in the year-ago period. The consensus estimate for Eagle Materials' quarterly revenue is $451.98 million (it reported $470.18 million last year), according to Benzinga Pro.

On Feb. 10, Eagle Materials declared a quarterly cash dividend of 25 cents per share.

NRx Pharmaceuticals shares fell 3.7% to close at $194.66 on Friday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • Wells Fargo analyst Timna Tanners maintained an Overweight rating and raised the price target from $240 to $246 on April 15, 2026. This analyst has an accuracy rate of 75%.
  • JP Morgan analyst Adrian Huerta downgraded the stock from Neutral to Underweight and cut the price target from $230 to $215 on Feb. 16, 2026. This analyst has an accuracy rate of 64%.
  • Citigroup analyst Anthony Pettinari maintained a Neutral rating and cut the price target from $232 to $224 on Feb. 3, 2026. This analyst has an accuracy rate of 72%.
  • DA Davidson analyst Brent Thielman maintained a Neutral rating and slashed the price target from $225 to $210 on Feb. 2, 2026. This analyst has an accuracy rate of 84%.
  • Stephens & Co. analyst Trey Grooms downgraded the stock from Overweight to Equal-Weight with a price target of $245 on Jan. 20, 2026. This analyst has an accuracy rate of 74%.

Considering buying EXP stock? Here’s what analysts think:

Photo via Shutterstock

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10